Last reviewed · How we verify
An Observational Study to Assess Back Pain in Patients With Severe Osteoporosis Treated With Teriparatide Versus Antiresorptives
The purpose of this study is to compare the effectiveness of teriparatide versus therapies that decrease bone loss to prevent new or worsening back pain in patients with osteoporosis seen in clinical practice.
Details
| Lead sponsor | Eli Lilly and Company |
|---|---|
| Status | COMPLETED |
| Enrolment | 650 |
| Start date | 2008-02 |
| Completion | 2010-12 |
Conditions
- Osteoporosis
Interventions
- teriparatide
- antiresorptives
Primary outcomes
- New or worsening back pain as measured by a specific question in the Back Pain Questionnaire — 12 months
Countries
Hong Kong, India, Malaysia, Mexico, Pakistan, Singapore, South Korea, Taiwan, Thailand